Real-Time Update: BiomX Inc (PHGE) Stock Navigates the Market with Up-to-Date Data

The stock of BiomX Inc (PHGE) has seen a 23.62% increase in the past week, with a 1.32% gain in the past month, and a 57.57% flourish in the past quarter. The volatility ratio for the week is 13.78%, and the volatility levels for the past 30 days are at 12.56% for PHGE. The simple moving average for the past 20 days is 1.68% for PHGE’s stock, with a 4.13% simple moving average for the past 200 days.

Is It Worth Investing in BiomX Inc (AMEX: PHGE) Right Now?

Additionally, the 36-month beta value for PHGE is 1.45.

The public float for PHGE is 19.17M and currently, short sellers hold a 1.14% ratio of that float. The average trading volume of PHGE on April 24, 2024 was 2.61M shares.

PHGE) stock’s latest price update

BiomX Inc (AMEX: PHGE) has experienced a rise in its stock price by 17.42 compared to its previous closing price of 0.30. However, the company has seen a gain of 23.62% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-23 that Abstract selected as a “Top Poster”, ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024 Abstract selected as a “Top Poster”, ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024

Analysts’ Opinion of PHGE

Many brokerage firms have already submitted their reports for PHGE stocks, with Ladenburg Thalmann repeating the rating for PHGE by listing it as a “Buy.” The predicted price for PHGE in the upcoming period, according to Ladenburg Thalmann is $25 based on the research report published on April 15, 2021 of the previous year 2021.

PHGE Trading at 9.72% from the 50-Day Moving Average

After a stumble in the market that brought PHGE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.47% of loss for the given period.

Volatility was left at 12.56%, however, over the last 30 days, the volatility rate increased by 13.78%, as shares surge +2.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +54.00% upper at present.

During the last 5 trading sessions, PHGE rose by +23.62%, which changed the moving average for the period of 200-days by -8.79% in comparison to the 20-day moving average, which settled at $0.3412. In addition, BiomX Inc saw 23.75% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PHGE starting from Oron Assaf, who sale 10,914 shares at the price of $0.37 back on Nov 29 ’23. After this action, Oron Assaf now owns 0 shares of BiomX Inc, valued at $4,072 using the latest closing price.

Oron Assaf, the Chief Business Officer of BiomX Inc, purchase 3,192 shares at $0.27 during a trade that took place back on May 22 ’23, which means that Oron Assaf is holding 10,914 shares at $872 based on the most recent closing price.

Stock Fundamentals for PHGE

Current profitability levels for the company are sitting at:

  • 66.43 for the present operating margin
  • 4.23 for the gross margin

The net margin for BiomX Inc stands at 69.06. The total capital return value is set at -0.38. Equity return is now at value -216.99, with -39.47 for asset returns.

Based on BiomX Inc (PHGE), the company’s capital structure generated 0.79 points at debt to capital in total, while cash flow to debt ratio is standing at -1.8. The debt to equity ratio resting at 3.85. The interest coverage ratio of the stock is -7.46.

Currently, EBITDA for the company is -26.81 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of -68.01. The receivables turnover for the company is -0.47for trailing twelve months and the total asset turnover is -0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.58.

Conclusion

In conclusion, BiomX Inc (PHGE) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts